ArticleInflammopharmacology2026
Phytochemical content, antioxidant and anti-inflammatory properties and wound healing effect of Chaiturus marrubiastrum: an in vitro and in vivo study.
Article in Inflammopharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medicinal plants have been traditionally used to treat wounds. The aim of this study was to investigate the antioxidant activity, wound healing effect and chemical content of the aerial parts of Chaiturus marrubiastrum (L.) Ehrh. ex Rchb. Pressure wound model in rats was used to evaluate the wound healing effect of the extracts. The antioxidant activity of the extract was evaluated using total antioxidant capacity, reducing power, metal chelation, DPPH and ABTS scavenging tests. The chemical profile of the extract was evaluated by LC-MS/MS analysis. The extract had 83.50 ± 0.11% and 70.73 ± 1.30% inhibition in DPPH and ABTS scavenging tests, respectively. The metal chelation capacity of the extract increased with increasing concentration. The reducing power of the extract (at 2 mg/mL) was similar to that of quercetin (3.521 ± 0.07, 3.831 ± 0.03, respectively). The most abundant substance in the extract was rosmarinic acid (165.611 mg/g extract). In vivo experiments, wound healing occurred faster in the group treated with C. marrubiastrum extracts in pressure wounds created on rats compared to the control groups. Histopathological analyses showed that connective tissue development and vascularization increased and inflammation decreased in this group. In addition, immunohistochemical analyses have shown that C. marrubiastrum extract reduces TNF-α, VEGF and caspase-3 levels, thus inhibiting inflammation and apoptosis. These findings suggest that the wound healing-accelerating effects of C. marrubiastrum are based on strong antioxidant and anti-inflammatory properties. It is concluded that future studies should optimize this extract for clinical use and evaluate its efficacy in humans.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.